UnitedHealth Group Files Regulation FD Disclosure

UnitedHealth Group Inc. filed Form 8-K with the Securities and Exchange Commission on May 11 2026 under CIK 0000731766 and accession number 0000731766-26-000129.

The filing covers Item 7.01 Regulation FD disclosure. Regulation FD requires public companies to disseminate material nonpublic information broadly to the marketplace rather than selectively. UnitedHealth Group the parent of UnitedHealthcare and Optum serves more than 49 million U.S. health insurance customers and processes hundreds of billions of dollars in annual medical claims.

The 8-K itself contains no verbatim text detailing the content of the disclosure beyond the checked item. Prior to this filing UnitedHealth Group maintained whatever internal controls governed the particular information at issue. The new state is that the company has placed the information on record with the SEC thereby satisfying its Regulation FD obligations as of the filing date of May 11 2026.

Downstream the filing starts the clock for any related obligations such as potential amendments to prior periodic reports or separate Item 8.01 disclosures if the information intersects with other reportable events. Market participants must incorporate the disclosed information into their analysis of UnitedHealth Group’s second-quarter 2026 performance.

The SEC can review the filing for compliance with fair-disclosure rules and may require additional clarification filings if the original disclosure is deemed incomplete. Standard SEC rules also require the company to retain supporting documentation for inspector review.

This marks the latest Regulation FD 8-K from the company in 2026. UnitedHealth Group last filed a similar Item 7.01 form in the prior fiscal year following an earlier selective-disclosure event. The company remains subject to ongoing quarterly and annual reporting deadlines under the Securities Exchange Act.